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cyclic ADP-ribose; intracellular Ca 2ϩ concentration A TYPE II TRANSMEMBRANE GLYCOPROTEIN, CD38, represents mammalian ADP-ribosyl cyclase (ADPR-cyclase) and is involved in T cell activation (18) and oxytocin secretion, which is closely associated with social behavior (20) , and acts mainly as an NAD glycohydrolase therewith regulating intracellular NAD ϩ levels (2, 40) . Studies have also suggested that ADPRcyclase(s) other than CD38 may exist in kidney, brain, and heart (3, 28) , including various cells (3, 4, 27, 28, 40, 41) . In addition, a bisphenyl compound has been shown to inhibit kidney ADPR-cyclase, but not CD38, with a high potency (27) . ADPR-cyclases generate a Ca 2ϩ -mobilizing second messenger, cyclic ADP-ribose (cADPR), from NAD ϩ (8, 13, 22) . The second messenger, cADPR, increases intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) through release of Ca 2ϩ from intracellular stores via ryanodine receptor and/or Ca 2ϩ influx through plasma membrane Ca 2ϩ channels (16, 22, 28, 29) . Production of cADPR by ADPR-cyclases including CD38 is stimulated by various G protein-coupled receptors (GPCRs) such as receptors for adrenaline (15) , angiotensin II (ANG II) (6), acetylcholine (26) , and interleukin-8 (IL-8) (29) . However, except for IL-8-mediated CD38 activation in lymphokine-activated killer (LAK) cells (29) , the molecular mechanism of ADPR-cyclase activation by other GPCRs has not been clarified. The major renin-angiotensin system effector, ANG II, plays critical roles in cell growth, vascular contraction, migration, and salt water retention (1, 7, 21) . Effects of ANG II are mediated by at least two structurally and pharmacologically distinct ANG II type 1 and 2 receptors (AT 1 R and AT 2 R, respectively) (7, 21) . The physiological and pathophysiological effects of ANG II are mainly exerted by AT 1 R activation (12, 21, 33) via complex interacting signaling pathways involving primary stimulation of phospholipase C (PLC) and Ca 2ϩ mobilization and secondary activation of protein tyrosine kinase (PTK), extracellular signal-regulated kinases-1 and -2 (Erk1/ 2), and phosphatidylinositol 3-kinase (PI3K)-dependent kinase Akt (12, 21, 30, 33) . ADPR-cyclase activation or cADPRmediated [Ca 2ϩ ] i increase by ANG II has also been observed in rat neonatal cardiomyocytes (17) and afferent arterioles (6) . However, the molecular mechanism(s) of ADPR-cyclase activation in ANG II signaling remains elusive.
In this study, we elucidated the molecular basis of ADPRcyclase activation in ANG II signaling in murine mesangial cells (MMCs) utilizing various pharmacological inhibitors, including an inhibitor of kidney ADPR-cyclase. We also examined the cellular responses involving ADPR-cyclase. The results showed that activation of ADPR-cyclase by ANG II involves a sequential activation of PI3K, PTK, and PLC␥1 and induces cell proliferation and protein synthesis. Culture of MMCs. SV40-transformed MMCs (MES-13) were obtained from America Type Culture Collection (ATCC; Rockville, MD) and maintained in DMEM containing 5% fetal bovine serum (FBS), 0.25 g/ml amphotericin B, 100 units/ml penicillin, and 100 units/ml streptomycin in a humidified incubator at 37°C in presence of 5% CO 2 and 95% air. Cells were passaged three times per week.
MATERIALS AND METHODS

Reagents
Measurement of intracellular cADPR concentration and ADPRcyclase activity.
Level of cADPR was measured using a cyclic enzymatic assay as described previously (11, 29) . ADPR-cyclase activity was measured using NGD ϩ as a substrate. Samples were incubated with NGD ϩ (200 M) in 0.1 M sodium phosphate buffer (pH 7.2) at 37°C for 10 min. Fluorescence of cGDPR in the solution was determined at excitation/emission wavelengths of 297/410 nm (Hitachi F-2000 fluorescence spectrophotometer).
Measurement of [Ca 2ϩ ]i. Changes in [Ca 2ϩ ]i in MMCs were determined as described previously (29) . MMCs grown to near confluence were made quiescent by serum deprivation overnight at 37°C. Starved cells were incubated with 5 M Fluo-3 AM (Molecular Probe, Eugene, OR) in HBSS (2 mM CaCl 2, 145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5 mM D-glucose, and 20 mM HEPES, pH 7.3) at 37°C for 40 min. The cells were washed three times with HBSS. Changes in [Ca 2ϩ ]i in MMCs were determined at 488 nm excitation/ 530 nm emission by an air-cooled argon laser system. The emitted fluorescence at 530 nm was collected using a photomultiplier. One image every 4 s for 400 s was scanned using a confocal microscope (Nikon, Japan). For the calculation of [Ca 2ϩ ]i, the method of Tsien et al. (37) 3 H]leucine for 6 h at 37°C. The cells were then washed once with phosphate-buffered saline (PBS), then treated with ice-cold 5% trichloroacetic acid (TCA) at 4°C for 15 min, and then washed twice in 5% TCA. The acid-insoluble material was dissolved in 2 N NaOH at room temperature and counted for radioactivity by liquid scintillation counting. All experiments were performed in triplicate.
Immunoblotting. Protein extraction and immunoblotting of MMCs were performed as previously described (29) . Cytosolic and nuclear fractions were prepared with Pierce NE-PER nuclear and cytoplasmic extraction kit according to the manufacturer's directions (Pierce, Rockford, IL). Proteins (20 g/lane) were resolved on 10 or 12% SDS-PAGE gel and transferred to polyvinylidene difluoride (PVDF; GE Healthcare, Little Chalfont, Buckinghamshire, UK) membranes. Blots were incubated with primary antibodies (phospho-Akt, Akt, phospho-Erk1/2, and Erk1/2, 1:2,500 dilution; NFAT3, 1:1,000 dilution) overnight at 4°C. The blots were rinsed four times with TTBS (Tris-buffered saline with Tween-20) and incubated with horseradish peroxidase-conjugated secondary antibodies (1:5,000 dilution of each antibody) for 1 h at room temperature. The binding of the antibodies was visualized using an enhanced chemiluminescence (ECL) system (Bio-Rad, Munich, Germany). Protein concentration was determined using a Bio-Rad protein assay kit, and known concentrations of bovine serum albumin (BSA) were used as the standard.
Immunoprecipitation. Immunoprecipitation of MMC lysates was performed as previously described (29) . In brief, cell lysates (600 g/lane) precleared with protein G-agarose were incubated with anti PLC␥1 mAb at 4°C for 12 h, and then protein G-agarose was added for an additional 1 h. Immunoprecipitates were washed four times with cell lysis buffer (1% Triton X-100, 145 mM NaCl, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, protease inhibitor cocktail, and 20 mM HEPES, pH 7.3) and boiled for 10 min. The proteins immunoprecipitated were resolved by 8% SDS-PAGE and transferred to PVDF membranes. After blocking with 5% skim milk in TTBS, the membrane was treated with an anti-tyrosine mAb (1:2,500 dilution), followed by horseradish peroxidease-conjugaed anti-mouse IgG (1:5,000 dilution).
Statistical analysis. All immunoreactive and phosphorylated signals were analyzed by densitometric scanning (Fuji Photo Film, Tokyo, Japan). Data represent means Ϯ SE of at least three separate experiments. Statistical comparisons were performed using one-way ANOVA followed by Scheffé's test. Statistical significance of difference between groups was determined using the Student's t-test. Statistical significance was set at P Ͻ 0.05.
RESULTS
ANG II induces a sustained rise of [Ca 2ϩ
] i and production of intracellular cADPR through AT 1 R. Treatment of MMCs with ANG II (150 nM) induced a sustained rise of [Ca 2ϩ ] i in the cells (Fig. 1A) . The ANG II-mediated rise of [Ca 2ϩ ] i was mediated by the AT 1 R, because pretreatment of the cells with losartan (1 M), an AT 1 R antagonist, completely abolished the rise of [Ca 2ϩ ] i , whereas pretreatment with PD123319 (1 M), an AT 2 R antagonist, had no effect (Fig. 1, A and B) . To examine whether ANG II signaling involves ADPR-cyclase, ANG II-mediated production of cADPR was measured. As shown in Fig. 1C , the production of cADPR was increased by ANG II, reaching maximum level at 60 s and subsequently decreasing with time. ANG II-mediated production of cADPR was significantly abrogated with losartan, but not by PD123319 (Fig. 1D ). These data suggest that ANG II stimulates ADPRcyclase and induces a sustained rise of [Ca 2ϩ ] i through AT 1 R. 
ANG II-induced increase of [Ca 2ϩ ] i in MMCs requires the activation of ADPR-cyclase.
To investigate whether the increase of intracellular Ca 2ϩ induced by ANG II/AT 1 R entails activation of ADPR-cyclase/cADPR production, an antagonistic cADPR analog, 8-Br-cADPR, and a kidney ADPR-cyclase inhibitor, DHAB, were utilized. As expected, treatment of MMCs with ANG II generated a sustained Ca 2ϩ increase ( Fig.  2A) . Pretreatment with 8-Br-cADPR or DHAB abrogated the late phase of the ANG II-induced Ca 2ϩ signals but not the initial spiky Ca 2ϩ rise (Fig. 2, A and B) . In support of the data, DHAB inhibited ANG II-mediated cADPR production (Fig.  2C) . These results indicate that activation of ADPR-cyclase and, in turn, cADPR production evokes the late-phase Ca (Fig. 3, A and B) . ANG II-induced Ca 2ϩ signals were completely inhibited by pretreatment with PLC inhibitor (U73122), PI3K inhibitor (LY294002), or inositol 1,4,5-trisphosphate receptor (IP 3 R) blocker (xestospongin C) (Fig. 3, C and D) . These results suggest that PLC and PI3K regulate IP 3 -mediated Ca 2ϩ release, and that the initial spiky Ca 2ϩ rise is a requisite for the late phase of Ca 2ϩ influx via L-type Ca 2ϩ channels. A previous study indicated that ANG II-induced elevation of [Ca 2ϩ ] i is mediated by PLC␥1 activated by genistein-sensitive PTK (31) . Therefore, we evaluated ANG II-stimulated phosphorylation of PLC␥1 with or without genistein, wortmannin, or DHAB. As presented in Fig. 3 , E and F, ANG II stimulated tyrosine phosphorylation of PLC␥1, and the tyrosine phosphorylation was completely inhibited by genistein or wortmannin but not by DHAB.
The above data indicate that PLC␥1, PI3K, and IP 3 regulate ANG II-mediated Ca 2ϩ signals. An involvement of these molecules in the activation of ADPR-cyclase by ANG II was examined by determining cADPR formation. The inhibitors of PI3K (wortmannin and LY294002), PLC (U73122), IP 3 R (xestospongin C), ADPR-cyclase (DHAB), and PTK (genistein) blocked completely the ANG II-mediated cADPR formation (Fig. 3G) . However, an Akt inhibitor did not inhibit the cADPR formation (Fig. 3G) . In addition, examination of the Ca 2ϩ effect on the ANG II-mediated cADPR formation showed that depletion of intracellular Ca 2ϩ with BAPTA inhibited the cADPR formation, whereas in the absence of extracellular Ca 2ϩ , the cADPR formation was increased to the control level measured in the presence of extracellular Ca 2ϩ (Fig. 3H) . These results together suggest that PI3K, PTK, and PLC␥1 are the upstream effectors of ADPR-cyclase in the ANG II signaling pathway, and that activation of ADPRcyclase requires an intracellular Ca 2ϩ rise, probably the IP 3 Rmediated Ca 2ϩ rise.
ANG II-induced Akt phosphorylation requires activation of ADPR-cyclase and intracellular Ca
2ϩ . To define the effectors, which were stimulated by ADPR-cyclase/cADPR signaling, ANG II-mediated phosphorylation of either Akt or Erk1/2 was evaluated by determining phospho-Akt and phospho-Erk1/2.
Treatment of MMCs with ANG II increased the levels of phospho-Akt and phospho-Erk1/2 in a time-dependent manner (Fig. 4, A and B) . Pretreatment of the cells with DHAB significantly reduced the level of phospho-Akt but not the level of phospho-Erk1/2 (Fig. 4, C and D) . Involvement of ADPRcyclase signaling in ANG II-induced Akt phosphorylation was further ascertained by using inhibitors of the upstream effectors of ADPR-cyclase. As shown in Fig. 4 , E and F, ANG IImediated Akt phosphorylation was inhibited by LY294002, U73122, and depletion of intracellular Ca 2ϩ with BAPTA. In the presence of extracellular Ca 2ϩ , 8-Br-cADPR inhibited ANG II-stimulated Akt phosphorylation, and cADPR additively enhanced ANG II-induced Akt phosphorylation (Fig. 4,  G and H) . Moreover, cADPR alone was also able to increase the Akt phosphorylation. On the other hand, neither ANG II nor cADPR stimulated Akt phosphorylation in the absence of extracellular Ca 2ϩ (Fig. 4, I and J). These results suggest that the ADPR-cyclase/cADPR-mediated Ca 2ϩ signal is required for Akt phosphorylation by ANG II.
DHAB inhibits ANG II-induced NFAT translocation into nuclear. In various cell types including mesangial cells (MCs), an increase in [Ca 2ϩ ] i induces nuclear translocation of NFATs via activation of calcineurin, a calcium-dependent serine/threonine phosphatase (9, 25, 35, 38, 42) . We therefore examined NFAT3 activation, since this transcription factor is known to be activated by ANG II (38) . ANG II increased the level of NFAT3 in the nuclear fraction, whereas the level in the cytosol fraction was reciprocally decreased (Fig. 5, A and B) . The increase of nuclear NFAT3 level and the decrease of cytosolic NFAT3 level were inhibited by DHAB, calcineurin inhibitor FK506, and wortmannin (Fig. 5, A and B) , indicating that the sustained Ca 2ϩ increase by ADPR-cyclase signaling induces NFAT3 activation in MMCs. We also examined whether NFAT activation by ANG II induced cell proliferation or (Fig. 5, C and D) . The ANG II-induced cell proliferation (Fig. 5E ) and protein synthesis (Fig. 5F ) were inhibited by FK506, wortmannin, and 8-Br-ADPR but not by the Akt inhibitor. These results indicate that ADPR-cyclase/cADPR play roles in ANG II-mediated NFAT3 activation, resulting in induction of cell proliferation and protein synthesis.
DISCUSSION
Our present studies have elucidated the molecular basis of ADPR-cyclase activation in ANG II signaling and the cellular responses induced by ADPR-cyclase signaling in MMCs. The results for the first time revealed that activation of ADPRcyclase by AT 1 R in MMCs is triggered by a sequential activation of PI3K, PTK, PLC␥1, and IP 3 -mediated Ca 2ϩ increase (Fig. 6) . Moreover, the results showed that the activation of ADPR-cyclase by ANG II induces a sustained Ca 2ϩ signal via L-type Ca 2ϩ channels and upregulates NFAT3 nuclear translocation and Akt phosphorylation, including cell proliferation and protein synthesis (Fig. 6) (14, 19, 24) .
Examination of the downstream effectors of ADPR-cyclase in ANG II signaling revealed that ADPR-cyclase activation resulted in increases in nuclear NFAT3 level and Akt phosphorylation. The NFAT3 activation, but not Akt activation, by ANG II stimulated cell proliferation and protein synthesis. However, it was of an interest to observe that ANG II-induced Akt phosphorylation required not only PI3K activity but also elevated [Ca 2ϩ ] i , which was mediated by activation of ADPRcyclase/cADPR production. In support of the results, Akt phosphorylation has been shown to require both PI3K activity and increased [Ca 2ϩ ] i in smooth muscle cells (23) . Moreover, PI3K-independent activation of Akt/protein kinase B in rat glomerular MCs by ANG II has also been reported (10) . Exact cellular responses of Akt in glomerular MCs should be examined in the future.
Finally, biochemical properties of kidney ADPR-cyclase are different from those of prototype ADPR-cyclase, CD38 (3, 4, 27, 28, 41) . Discovery of a potent inhibitor of kidney ADPRcyclase has made possible the elucidation of the involvement of ADPR-cyclase/cADPR in ANG II signaling in MMCs. Our findings have indicated that ADPR-cyclase in MMCs may play a central role in switching the external signaling events to cell proliferation and protein synthesis. Our study may also provide a new therapeutic target, namely ADPR-cyclase, in ANG II-induced pathogenesis in kidney.
